Instinct Bio Technical Company Holdings Inc. Operational Update

Instinct Bio Technical Company Holdings Inc. has provided an operational update regarding its GENRÊVER CLINIC platform in Indonesia and product development initiatives with Invitrx Therapeutics, Inc. and PT Parva Candela. The company has secured a 213 m² premises in Gandaria, South Jakarta, for its first clinic, with construction underway and a targeted opening by the end of December 2026. Preliminary subscription pricing tiers have been established, with treatment availability subject to membership terms and other conditions. In collaboration with Invitrx, an initial GENRÊVER-branded cosmetic product line is being considered for US manufacturing, with a target commencement within 2026. Additionally, with PT Parva Candela, two cosmetic product candidates for the Indonesian market, a premium UV cream and a moisturizing gel, are identified for potential production within 2026, pending development and regulatory approvals. Further details are available on the company's website.